Related Experiment Video
Updated: Aug 22, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?
Gabriele Bammer1, Wim van den Brink, Patrick Gschwend
1National Center for Epidemiology and Population Health, The Australian National University, Canberra, ACT 0200, Australia. Gabriele.Bammer@anu.edu.au
Abstract:
Following on from last edition's Harm Reduction Digest on drug consumption facilities this Digest investigates what can be learnt from the Swiss and Dutch trials of heroin prescribing about the unintended consequences of this controversial intervention to reduce heroin-related harm. The authors of the paper bring considerable experience in the implementation and evaluation of such schemes in Europe and their consideration in Australia. The paper systematically addresses concerns about heroin prescribing and suggests further research to respond to some unanswered questions.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmaceutical Poisoning: Potential Scenarios
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact

